[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sophocarpidine (CAS: 519-02-8) Market Growth 2018-2023

December 2018 | 138 pages | ID: GE05E0DF31EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

According to this study, over the next five years the Sophocarpidine (CAS:519-02-8) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Sophocarpidine (CAS:519-02-8) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Sophocarpidine (CAS:519-02-8) market by product type, application, key manufacturers and key regions and countries.

This study considers the Sophocarpidine (CAS:519-02-8) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
  • High Purity
  • Low Purity
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
  • Pharmaceuticals
  • Pesticides
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  • Fujie Pharmaceutical
  • QHL Pharma
  • Select Botanical
  • Indena
  • Qinghai Lake Pharmaceuticals
  • TIANSHAN Pharmaceuticals
  • Selco Wirkstoffe Vertriebs GmbH
  • Jiangsu Tiansheng Pharmaceutical
  • Tiansheng Pharmaceutical
  • Hubei Zhongliao Chemical Co., LTD
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES
  • To study and analyze the global Sophocarpidine (CAS:519-02-8) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Sophocarpidine (CAS:519-02-8) market by identifying its various subsegments.
  • Focuses on the key global Sophocarpidine (CAS:519-02-8) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Sophocarpidine (CAS:519-02-8) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Sophocarpidine (CAS:519-02-8) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 GLOBAL SOPHOCARPIDINE (CAS:519-02-8) CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sophocarpidine (CAS:519-02-8) Consumption 2013-2023
  2.1.2 Sophocarpidine (CAS:519-02-8) Consumption CAGR by Region
2.2 Sophocarpidine (CAS:519-02-8) Segment by Type
  2.2.1 High Purity
  2.2.2 Low Purity
2.3 Sophocarpidine (CAS:519-02-8) Consumption by Type
  2.3.1 Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
  2.3.2 Global Sophocarpidine (CAS:519-02-8) Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Sophocarpidine (CAS:519-02-8) Sale Price by Type (2013-2018)
2.4 Sophocarpidine (CAS:519-02-8) Segment by Application
  2.4.1 Pharmaceuticals
  2.4.2 Pesticides
  2.4.3 Others
2.5 Sophocarpidine (CAS:519-02-8) Consumption by Application
  2.5.1 Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
  2.5.2 Global Sophocarpidine (CAS:519-02-8) Value and Market Share by Application (2013-2018)
  2.5.3 Global Sophocarpidine (CAS:519-02-8) Sale Price by Application (2013-2018)

3 GLOBAL SOPHOCARPIDINE (CAS:519-02-8) BY PLAYERS

3.1 Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Players
  3.1.1 Global Sophocarpidine (CAS:519-02-8) Sales by Players (2016-2018)
  3.1.2 Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Players (2016-2018)
3.2 Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Players
  3.2.1 Global Sophocarpidine (CAS:519-02-8) Revenue by Players (2016-2018)
  3.2.2 Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Players (2016-2018)
3.3 Global Sophocarpidine (CAS:519-02-8) Sale Price by Players
3.4 Global Sophocarpidine (CAS:519-02-8) Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Sophocarpidine (CAS:519-02-8) Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Sophocarpidine (CAS:519-02-8) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 SOPHOCARPIDINE (CAS:519-02-8) BY REGIONS

4.1 Sophocarpidine (CAS:519-02-8) by Regions
  4.1.1 Global Sophocarpidine (CAS:519-02-8) Consumption by Regions
  4.1.2 Global Sophocarpidine (CAS:519-02-8) Value by Regions
4.2 Americas Sophocarpidine (CAS:519-02-8) Consumption Growth
4.3 APAC Sophocarpidine (CAS:519-02-8) Consumption Growth
4.4 Europe Sophocarpidine (CAS:519-02-8) Consumption Growth
4.5 Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Growth

5 AMERICAS

5.1 Americas Sophocarpidine (CAS:519-02-8) Consumption by Countries
  5.1.1 Americas Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018)
  5.1.2 Americas Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018)
5.2 Americas Sophocarpidine (CAS:519-02-8) Consumption by Type
5.3 Americas Sophocarpidine (CAS:519-02-8) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Sophocarpidine (CAS:519-02-8) Consumption by Countries
  6.1.1 APAC Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018)
  6.1.2 APAC Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018)
6.2 APAC Sophocarpidine (CAS:519-02-8) Consumption by Type
6.3 APAC Sophocarpidine (CAS:519-02-8) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Sophocarpidine (CAS:519-02-8) by Countries
  7.1.1 Europe Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018)
  7.1.2 Europe Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018)
7.2 Europe Sophocarpidine (CAS:519-02-8) Consumption by Type
7.3 Europe Sophocarpidine (CAS:519-02-8) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sophocarpidine (CAS:519-02-8) by Countries
  8.1.1 Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018)
8.2 Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Type
8.3 Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Sophocarpidine (CAS:519-02-8) Distributors
10.3 Sophocarpidine (CAS:519-02-8) Customer

11 GLOBAL SOPHOCARPIDINE (CAS:519-02-8) MARKET FORECAST

11.1 Global Sophocarpidine (CAS:519-02-8) Consumption Forecast (2018-2023)
11.2 Global Sophocarpidine (CAS:519-02-8) Forecast by Regions
  11.2.1 Global Sophocarpidine (CAS:519-02-8) Forecast by Regions (2018-2023)
  11.2.2 Global Sophocarpidine (CAS:519-02-8) Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Sophocarpidine (CAS:519-02-8) Forecast by Type
11.8 Global Sophocarpidine (CAS:519-02-8) Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Fujie Pharmaceutical
  12.1.1 Company Details
  12.1.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.1.3 Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Fujie Pharmaceutical News
12.2 QHL Pharma
  12.2.1 Company Details
  12.2.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.2.3 QHL Pharma Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 QHL Pharma News
12.3 Select Botanical
  12.3.1 Company Details
  12.3.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.3.3 Select Botanical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Select Botanical News
12.4 Indena
  12.4.1 Company Details
  12.4.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.4.3 Indena Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Indena News
12.5 Qinghai Lake Pharmaceuticals
  12.5.1 Company Details
  12.5.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.5.3 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Qinghai Lake Pharmaceuticals News
12.6 TIANSHAN Pharmaceuticals
  12.6.1 Company Details
  12.6.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.6.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 TIANSHAN Pharmaceuticals News
12.7 Selco Wirkstoffe Vertriebs GmbH
  12.7.1 Company Details
  12.7.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.7.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Selco Wirkstoffe Vertriebs GmbH News
12.8 Jiangsu Tiansheng Pharmaceutical
  12.8.1 Company Details
  12.8.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.8.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Jiangsu Tiansheng Pharmaceutical News
12.9 Tiansheng Pharmaceutical
  12.9.1 Company Details
  12.9.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.9.3 Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Tiansheng Pharmaceutical News
12.10 Hubei Zhongliao Chemical Co., LTD
  12.10.1 Company Details
  12.10.2 Sophocarpidine (CAS:519-02-8) Product Offered
  12.10.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Hubei Zhongliao Chemical Co., LTD News

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Sophocarpidine (CAS:519-02-8)
Table Product Specifications of Sophocarpidine (CAS:519-02-8)
Figure Sophocarpidine (CAS:519-02-8) Report Years Considered
Figure Market Research Methodology
Figure Global Sophocarpidine (CAS:519-02-8) Consumption Growth Rate 2013-2023 (K MT)
Figure Global Sophocarpidine (CAS:519-02-8) Value Growth Rate 2013-2023 ($ Millions)
Table Sophocarpidine (CAS:519-02-8) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of High Purity
Table Major Players of High Purity
Figure Product Picture of Low Purity
Table Major Players of Low Purity
Table Global Consumption Sales by Type (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Revenue by Type (2013-2018) ($ million)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Sophocarpidine (CAS:519-02-8) Value Market Share by Type (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Sale Price by Type (2013-2018)
Figure Sophocarpidine (CAS:519-02-8) Consumed in Pharmaceuticals
Figure Global Sophocarpidine (CAS:519-02-8) Market: Pharmaceuticals (2013-2018) (K MT)
Figure Global Sophocarpidine (CAS:519-02-8) Market: Pharmaceuticals (2013-2018) ($ Millions)
Figure Global Pharmaceuticals YoY Growth ($ Millions)
Figure Sophocarpidine (CAS:519-02-8) Consumed in Pesticides
Figure Global Sophocarpidine (CAS:519-02-8) Market: Pesticides (2013-2018) (K MT)
Figure Global Sophocarpidine (CAS:519-02-8) Market: Pesticides (2013-2018) ($ Millions)
Figure Global Pesticides YoY Growth ($ Millions)
Figure Sophocarpidine (CAS:519-02-8) Consumed in Others
Figure Global Sophocarpidine (CAS:519-02-8) Market: Others (2013-2018) (K MT)
Figure Global Sophocarpidine (CAS:519-02-8) Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Value by Application (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share by Application (2013-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Value Market Share by Application (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Sale Price by Application (2013-2018)
Table Global Sophocarpidine (CAS:519-02-8) Sales by Players (2016-2018) (K MT)
Table Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Players (2016-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Players in 2016
Figure Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Players in 2017
Table Global Sophocarpidine (CAS:519-02-8) Revenue by Players (2016-2018) ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Players (2016-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Players in 2016
Figure Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Players in 2017
Table Global Sophocarpidine (CAS:519-02-8) Sale Price by Players (2016-2018)
Figure Global Sophocarpidine (CAS:519-02-8) Sale Price by Players in 2017
Table Global Sophocarpidine (CAS:519-02-8) Manufacturing Base Distribution and Sales Area by Players
Table Players Sophocarpidine (CAS:519-02-8) Products Offered
Table Sophocarpidine (CAS:519-02-8) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Sophocarpidine (CAS:519-02-8) Consumption by Regions 2013-2018 (K MT)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Regions 2013-2018
Figure Global Sophocarpidine (CAS:519-02-8) Consumption Market Share by Regions 2013-2018
Table Global Sophocarpidine (CAS:519-02-8) Value by Regions 2013-2018 ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share by Regions 2013-2018
Figure Global Sophocarpidine (CAS:519-02-8) Value Market Share by Regions 2013-2018
Figure Americas Sophocarpidine (CAS:519-02-8) Consumption 2013-2018 (K MT)
Figure Americas Sophocarpidine (CAS:519-02-8) Value 2013-2018 ($ Millions)
Figure APAC Sophocarpidine (CAS:519-02-8) Consumption 2013-2018 (K MT)
Figure APAC Sophocarpidine (CAS:519-02-8) Value 2013-2018 ($ Millions)
Figure Europe Sophocarpidine (CAS:519-02-8) Consumption 2013-2018 (K MT)
Figure Europe Sophocarpidine (CAS:519-02-8) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption 2013-2018 (K MT)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Value 2013-2018 ($ Millions)
Table Americas Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018) (K MT)
Table Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries (2013-2018)
Figure Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries in 2017
Table Americas Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018) ($ Millions)
Table Americas Sophocarpidine (CAS:519-02-8) Value Market Share by Countries (2013-2018)
Figure Americas Sophocarpidine (CAS:519-02-8) Value Market Share by Countries in 2017
Table Americas Sophocarpidine (CAS:519-02-8) Consumption by Type (2013-2018) (K MT)
Table Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Figure Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type in 2017
Table Americas Sophocarpidine (CAS:519-02-8) Consumption by Application (2013-2018) (K MT)
Table Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Figure Americas Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application in 2017
Figure United States Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure United States Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Canada Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Canada Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Mexico Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Mexico Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Table APAC Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018) (K MT)
Table APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries (2013-2018)
Figure APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries in 2017
Table APAC Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018) ($ Millions)
Table APAC Sophocarpidine (CAS:519-02-8) Value Market Share by Countries (2013-2018)
Figure APAC Sophocarpidine (CAS:519-02-8) Value Market Share by Countries in 2017
Table APAC Sophocarpidine (CAS:519-02-8) Consumption by Type (2013-2018) (K MT)
Table APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Figure APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type in 2017
Table APAC Sophocarpidine (CAS:519-02-8) Consumption by Application (2013-2018) (K MT)
Table APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Figure APAC Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application in 2017
Figure China Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure China Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Japan Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Japan Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Korea Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Korea Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure India Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure India Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Australia Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Australia Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Table Europe Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018) (K MT)
Table Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries (2013-2018)
Figure Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries in 2017
Table Europe Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018) ($ Millions)
Table Europe Sophocarpidine (CAS:519-02-8) Value Market Share by Countries (2013-2018)
Figure Europe Sophocarpidine (CAS:519-02-8) Value Market Share by Countries in 2017
Table Europe Sophocarpidine (CAS:519-02-8) Consumption by Type (2013-2018) (K MT)
Table Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Figure Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type in 2017
Table Europe Sophocarpidine (CAS:519-02-8) Consumption by Application (2013-2018) (K MT)
Table Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Figure Europe Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application in 2017
Figure Germany Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Germany Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure France Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure France Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure UK Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure UK Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Italy Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Italy Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Russia Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Russia Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Spain Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Spain Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Countries in 2017
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Value Market Share by Countries in 2017
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Type in 2017
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption Market Share by Application in 2017
Figure Egypt Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Egypt Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure South Africa Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure South Africa Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Israel Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Israel Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure Turkey Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure Turkey Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Sophocarpidine (CAS:519-02-8) Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Sophocarpidine (CAS:519-02-8) Value Growth 2013-2018 ($ Millions)
Table Sophocarpidine (CAS:519-02-8) Distributors List
Table Sophocarpidine (CAS:519-02-8) Customer List
Figure Global Sophocarpidine (CAS:519-02-8) Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Sophocarpidine (CAS:519-02-8) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Forecast by Regions
Table Global Sophocarpidine (CAS:519-02-8) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share Forecast by Regions
Figure Americas Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Americas Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure APAC Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure APAC Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Europe Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Europe Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Middle East & Africa Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure United States Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure United States Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Canada Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Canada Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Mexico Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Mexico Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Brazil Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Brazil Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure China Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure China Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Japan Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Japan Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Korea Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Korea Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Southeast Asia Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Southeast Asia Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure India Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure India Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Australia Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Australia Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Germany Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Germany Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure France Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure France Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure UK Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure UK Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Italy Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Italy Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Russia Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Russia Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Spain Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Spain Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Egypt Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Egypt Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure South Africa Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure South Africa Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Israel Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Israel Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure Turkey Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure Turkey Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Figure GCC Countries Sophocarpidine (CAS:519-02-8) Consumption 2018-2023 (K MT)
Figure GCC Countries Sophocarpidine (CAS:519-02-8) Value 2018-2023 ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Forecast by Type (2018-2023) (K MT)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Share Forecast by Type (2018-2023)
Table Global Sophocarpidine (CAS:519-02-8) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share Forecast by Type (2018-2023)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Forecast by Application (2018-2023) (K MT)
Table Global Sophocarpidine (CAS:519-02-8) Consumption Market Share Forecast by Application (2018-2023)
Table Global Sophocarpidine (CAS:519-02-8) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Sophocarpidine (CAS:519-02-8) Value Market Share Forecast by Application (2018-2023)
Table Fujie Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table QHL Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table QHL Pharma Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure QHL Pharma Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Select Botanical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Select Botanical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Select Botanical Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Indena Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indena Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Indena Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Qinghai Lake Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qinghai Lake Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Qinghai Lake Pharmaceuticals Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table TIANSHAN Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Selco Wirkstoffe Vertriebs GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Jiangsu Tiansheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Tiansheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)
Table Hubei Zhongliao Chemical Co., LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Market Share (2016-2018)


More Publications